Background: Around 12% of world population has been infected by renal stone disease which has multiphase etiological factors with high
recurrence rate. Thus, in order to reduce the recurrence rate, use of homoeopathic intervention can be the most effective alternative option and
Sarsaparilla is one of the frequently prescribed medicines by homoeopath in renal stones.
Aim: To nd out the inhibitory action of homoeopathic medicine Sarsaparilla Q, 6C, 12C, 30C, 200C, 1M on calcium oxalate and calcium
phosphate crystallization by in vitro study.
Methodology: In vitro crystallisation of calcium oxalate and calcium phosphate was carried out to evaluate effectiveness of Homoeopathic
Medicine Sarsaparilla as an inhibitor. Calcium Oxalate crystallisation assay was experimented by using JASCO-UV/VISIBLE-630
Spectrophotometer. Slope of Nucleation and Aggregation phases is calculated using linear regression analysis and percentage of inhibition was
calculated. Calcium phosphate crystallisation inhibition by Sarsaparilla was calculated by measuring concentration of calcium and phosphate ions,
using Digital Photo colorimeter by Trinder and Gomeri method respectively. Antioxidant activity of Sarsaparilla Mother Tincture and potencies
was measured by DPPH free radical scavenging assay by spectrophotometer.
Result: Maximum inhibition of calcium oxalate crystallisation has been noticed in Sarsaparilla Mother Tincture and 1M potency. While
Sarsaparilla 30C showing maximum inhibition of Calcium Phosphate crystallisation. Sarsaparilla mother tincture was able to decolorize during
DPPH assay in which Inhibition % was decreased as potency increased (Q>30C>1M).
Conclusion: The present in vitro study has shown potential role of Homoeopathic medicine Sarsaparilla as an inhibitor of calcium oxalate and
calcium phosphate crystallisation.